Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Gilead Sciences
Gilead Sciences
Gilead Sciences will lay off 114 staffers based out of former Immunomedics headquarters
Fierce Pharma
Tue, 03/8/22 - 11:05 pm
Gilead Sciences
Immunomedics
Trodelvy
layoffs
Gilead says breast cancer drug succeeded in key study, but offers few details
BioPharma Dive
Mon, 03/7/22 - 10:52 pm
Gilead Sciences
Trodelvy
clinical trials
M&A
breast cancer
FDA regulatory roundup: two approvals, three rejections & one clinical hold
MedCity News
Sun, 03/6/22 - 11:08 pm
FDA
JNJ
CTI BioPharma
Gilead Sciences
Amryt Pharma
Reata Pharmaceuticals
Rare disease and neurology take outs tick higher
EP Vantage
Wed, 03/2/22 - 10:03 am
M&A
AbbVie
AstraZeneca
Bristol Myers Squibb
JNJ
Gilead Sciences
Jazz Pharmaceuticals
Merck
Pfizer
Sanofi
rare disease
neurology
FDA rejects Gilead's closely watched HIV drug
BioPharma Dive
Tue, 03/1/22 - 10:05 pm
Gilead Sciences
HIV
FDA
lenacapavir
Gilead rejigs HIV immunotherapy pact, grabs a stake in biotech partner
Endpoints
Wed, 02/16/22 - 10:45 am
Gilead Sciences
HUV
Hookipa
Tracking Gilead's 4 Big Stories and a Lawsuit in 2022
Motley Fool
Tue, 02/15/22 - 10:31 am
Gilead Sciences
GSK
legal
ViiV Healthcare
COVID-19 treatments earned 4 drugmakers $14B in 2021
Beckers Hospital Review
Tue, 02/8/22 - 11:50 pm
Eli Lilly
Gilead Sciences
Merck
Regeneron
COVID-19
earnings
RedHill’s oral drug boosts Veklury efficacy in severe COVID
Pharmaforum
Tue, 02/8/22 - 09:54 am
Redhill Biopharma
COVID-19
Veklury
Gilead Sciences
Gilead's CD47 clinical hold expands as CEO O'Day expresses 'sense of urgency' in getting trials back on track
Fierce Biotech
Wed, 02/2/22 - 12:15 pm
Gilead Sciences
clinical trials
clinical hold
magrolimab
AML
MDS
GSK to get $1.25 bln to settle HIV drug patent row with Gilead
Reuters
Wed, 02/2/22 - 11:01 am
GSK
Gilead Sciences
HIV
Biktarvy
patents
Gilead's $4.9B oncology bet hit with partial clinical hold, forcing pause of pivotal trials and raising doubts about CD47
Fierce Biotech
Wed, 01/26/22 - 11:12 am
Gilead Sciences
magrolimab
anti-CD47
FDA
clinical trials
oncology
clinical hold
Gilead tags along again to support cell therapy biotech Kyverna in $85M fundraising
Fierce Biotech
Wed, 01/26/22 - 10:38 am
Gilead Sciences
Kyverna Therapeutics
funding
cell therapy
US turns to Gilead's COVID-19 drug to help counter omicron
BioPharma Dive
Mon, 01/24/22 - 10:04 am
Gilead Sciences
Veklury
COVID-19
Omicron COVID-19 variant
Failing to confirm clinical benefit, Gilead pulls 2 accelerated approval indications for cancer drug
Endpoints
Fri, 01/21/22 - 11:07 am
Gilead Sciences
Zydelig
follicular B-cell non-Hodgkin lymphoma
small lymphocytic leukemia
Gilead says a network of suppliers and distributors sold tens of thousands of fake versions of its HIV meds
Endpoints
Wed, 01/19/22 - 11:01 am
Gilead Sciences
HUV
drug counterfeiting
10 clinical trials to watch in the first half of 2022
BioPharma Dive
Mon, 01/3/22 - 10:46 am
clinical trials
Pfizer
Arena Pharmaceuticals
etrasimod
Sanofi
GSK
vaccines
COVID-19
Roche
gantenerumab
AbbVie
Gilead Sciences
Trodelvy
Karuna Therapeutics
KarXT
Intercept Pharma
obeticholic acid
Allogene
ALLO-501a
FDA slaps a hold on Gilead's injectable HIV treatment over concerns about potential glass contaminants
Endpoints
Wed, 12/22/21 - 11:01 am
Gilead Sciences
FDA
HIV
lenacapavir
clinical trials
clinical hold
Gilead’s Yescarta in line for $1.5B sales in earlier lymphoma thanks to game-changing data, fast production: analyst
Fierce Pharma
Thu, 12/16/21 - 11:57 pm
Gilead Sciences
Yescarta
CAR-T
Humana, Centene sue drugmakers, alleging anticompetitive practices on HIV drugs
BioPharma Dive
Thu, 12/16/21 - 10:45 am
Humana
Centene
generics
anticompetitive practices
Gilead Sciences
Bristol Myers Squibb
JNJ
Teva Pharmaceuticals
Pages
« first
‹ previous
…
5
6
7
8
9
10
11
12
13
…
next ›
last »